Vol. 5 No. 1 (2017) | ADMET and DMPK

Vol. 5 No. 1 (2017)

Published: 24-03-2017

Reviews

Tyrosine kinase inhibitors: new molecules in non-small cell lung cancer (EGFR AND ALK)

Fernando Franco, Miriam Mendez, Lourdes Gutierrez, Mariano Provencio

ADMET and DMPK, Vol. 5 No. 1 (2017), 1-8

Published 24-03-2017;

DOI: https://doi.org/10.5599/admet.5.1.352
- PDF
Biomembrane mimics and their roles in anti-bacterial drug discovery

Xiaohui Hu, Kin Tam

ADMET and DMPK, Vol. 5 No. 1 (2017), 9-13

Published 24-03-2017;

DOI: https://doi.org/10.5599/admet.5.1.375
- PDF

Original Scientific Articles

In vitro membrane binding and protein binding (IAM MB/PB technology) to estimate in vivo distribution: applications in early drug discovery

Klara Livia Valko, Simon P. Teague, Charles Pidgeon

ADMET and DMPK, Vol. 5 No. 1 (2017), 14-38

Published 24-03-2017;

DOI: https://doi.org/10.5599/admet.5.1.373
- PDF
Biorelevant dissolution of candesartan cilexetil

Lucie Gruberová, Bohumil Kratochvil

ADMET and DMPK, Vol. 5 No. 1 (2017), 39-46

Published 24-03-2017;

DOI: https://doi.org/10.5599/admet.5.1.346
- PDF
The inhibition of adenylate kinase by 2,4-thiazolidinedione evaluated by protein-ligand docking

Mihaela Ileana Ionescu

ADMET and DMPK, Vol. 5 No. 1 (2017), 47-56

Published 24-03-2017;

DOI: https://doi.org/10.5599/admet.5.1.327
- PDF